Autophagy-focused Casma Therapeutics debuts with $58.5 million from Third Rock

Wednesday, July 25, 2018 - 14:51 in Health & Medicine

The biotech will first tackle lysosomal storage disorders

Read the whole article on

Get the latest and most popular science news articles of the week in your Inbox! It's free!